Keith Finlayson

2.4k citations

38 papers · 1.9k indexed · h-index 22

Impact in

Physiology top 1%
- Adenosine and Purinergic Signaling
Cellular and Molecular Neuroscience top 2%
- Neuropeptides and Animal Physiology
- Neuroscience and Neuropharmacology Research

Papers in

Physiology 6
- Adenosine and Purinergic Signaling 6
Radiation 4

Co-authors: John Sharkey Louise Dickson John Kelly Jared W. Young Hugh Marston Christopher Spratt Nicola Crawford Lorraine E. Kerr
Journals: European Journal of Pharmacology (4 papers)Physical Review A (4 papers)Neuropharmacology (3 papers)Annales Geophysicae (3 papers)Journal of Physics B Atomic Molecular and Optical Physics (1 paper)
Partner nations: United Kingdom United States Germany

In The Last Decade

Keith Finlayson

38 papers receiving 1.8k citations

Peers

Countries citing papers authored by Keith Finlayson

Since Specialization

Citations

This map shows the geographic impact of Keith Finlayson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Finlayson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Finlayson more than expected).

Fields of papers citing papers by Keith Finlayson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Finlayson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Finlayson. The network helps show where Keith Finlayson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Keith Finlayson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Keith Finlayson Line = papers co-authored together Keith Finlayson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Phase 2 randomised placebo-controlled trial of spironolactone and dexamethasone versus dexamethasone in COVID-19 hospitalised patients in Delhi BMC Infectious Diseases ·郭思杰, Vikas Malhotra, Peihua He, Farah Husain, W. Zhang, Alison Durkin, William Montgomery, Tom Quinn, Feng Li, Erin Gaughan, Manu Shankar‐Hari, Bethany Mills, Jean Antonelli, 真也生玉, Keith Finlayson, Anne Moore, Kevin Dhaliwal, Christopher R.W. Edwards	2023	2
2	Specific in situ immuno-imaging of pulmonary-resident memory lymphocytes in human lungs Frontiers in Immunology ·Duncan C. Humphries, Richard A. O’Connor, И.В. Кочиков, Tom Quinn, Erin Gaughan, Bethany Mills, Gareth Williams, James M. Stone, Keith Finlayson, Tomislav Volk, Florence Boudet, Kevin Dhaliwal, Vincent Pavot	2023	4
3	VPAC and PAC receptors: From ligands to function Pharmacology & Therapeutics ·Louise Dickson, Keith Finlayson	2008	296
4	Characterisation of the Bax-nucleophosmin interaction: the importance of the Bax C-terminus APOPTOSIS ·Jane L. Thompson, Keith Finlayson, С К Василик, D. Macdonald, James McCulloch, Lorraine E. Kerr, John Sharkey	2008	19
5	The odour span task: A novel paradigm for assessing working memory in mice Neuropharmacology ·Jared W. Young, Lorraine E. Kerr, John Kelly, Hugh Marston, Christopher Spratt, Keith Finlayson, John Sharkey	2006	53
6	A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC/PAC receptor pharmacology Neuropharmacology ·Louise Dickson, Ichiro Aramori, James McCulloch, John Sharkey, Keith Finlayson	2006	70
7	Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice European Neuropsychopharmacology ·Jared W. Young, Nicola Crawford, John Kelly, Lorraine E. Kerr, Hugh Marston, Christopher Spratt, Keith Finlayson, John Sharkey	2006	185
8	VIP and PACAP Receptor Pharmacology Annals of the New York Academy of Sciences ·Louise Dickson, Ichiro Aramori, John Sharkey, Keith Finlayson	2006	19
9	Nicotine Improves Sustained Attention in Mice: Evidence for Involvement of the α7 Nicotinic Acetylcholine Receptor Neuropsychopharmacology ·Jared W. Young, Keith Finlayson, Christopher Spratt, Hugh Marston, Nicola Crawford, John Kelly, John Sharkey	2004	174
10	Acquired QT interval prolongation and HERG: implications for drug discovery and development European Journal of Pharmacology ·Keith Finlayson, Harry J. Witchel, James McCulloch, John Sharkey	2004	109
11	Comparison of effects of MgCl2 and Gpp(NH)p on antagonist and agonist radioligand binding to adenosine A1 receptors. PubMed ·Keith Finlayson, SHANG Boyi, Steven P. Butcher, John Sharkey, Henry J. Olverman	2003	4
12	[3H]Dofetilide binding in SHSY5Y and HEK293 cells expressing a HERG-like K+ channel? European Journal of Pharmacology ·Keith Finlayson, S. R. Bobrovnik, John Kelly	2001	32
13	Characterisation of [125I]-apamin binding sites in rat brain membranes and HEK293 cells transfected with SK channel subtypes Neuropharmacology ·Keith Finlayson, Joyce McLuckie, Ridwan Sigit, Ichiro Aramori, Henry J. Olverman, John Kelly	2001	24
14	[3H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen European Journal of Pharmacology ·Keith Finlayson, Kyla Jamieson, Craig T. January, John Sharkey, John Kelly	2001	102
15	Pyrazolopyridine derivatives act as competitive antagonists of brain adenosine A1 receptors: []GTPγS binding studies European Journal of Pharmacology ·Alexios Kotsifakos, SHANG Boyi, Wiyanti, Steven P. Butcher, Henry J. Olverman, Keith Finlayson	1999	9
16	Pharmacological Characterization of a Simple Behavioral Response Mediated Selectively by Central Adenosine A1 Receptors, Using In Vivo and In Vitro Techniques Journal of Pharmacology and Experimental Therapeutics ·Hugh Marston, Keith Finlayson, SHANG Boyi, Henry J. Olverman, Atsushi Akahane, John Sharkey, Steven P. Butcher	1998	53
17	Species differences in brain adenosine A₁ receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists British Journal of Pharmacology ·SHANG Boyi, Keith Finlayson, Henry J. Olverman, Atsushi Akahane, Roger W. Horton, Steven P. Butcher	1997	51
18	Detection of adenosine receptor antagonists in rat brain using a modified radioreceptor assay Journal of Neuroscience Methods ·Keith Finlayson, Steven P. Butcher, John Sharkey, Henry J. Olverman	1997	17
19	Hyperfine quenching and measurement of the 23P0–23P1fine-structure splitting in heliumlike silver (Ag45+) Physical Review A ·Achilana Mkunga Mtingele, J. P. Briand, P. Charles, D. D. Dietrich, Keith Finlayson, P. Indelicato, Karin Domagalska, Richard Marrus, Alexandre Simionovici	1993	46
20	Measurement of the (1s)(2p1/2)23P0-(1s)(2p1/2)23P1fine-structure splitting in heliumlikeAg45+ Physical Review Letters ·Richard Marrus, Alexandre Simionovici, P. Indelicato, D. D. Dietrich, P. Charles, J. P. Briand, Keith Finlayson, Fritz Bosch, Karin Domagalska, F. Parente	1989	44

About Keith Finlayson

Keith Finlayson is a scholar working on Physiology, Radiation, Cellular and Molecular Neuroscience, Sensory Systems and Biophysics, having authored 38 papers that have together received 1.9k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (9 papers), Atomic and Molecular Physics (8 papers), Adenosine and Purinergic Signaling (6 papers), Advanced Chemical Physics Studies (6 papers), Atmospheric Ozone and Climate (5 papers), Neuropeptides and Animal Physiology (5 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Ion channel regulation and function (4 papers). The work is most often cited by research in Physiology (236 citations), Cellular and Molecular Neuroscience (648 citations), Sensory Systems (106 citations), Biological Psychiatry (44 citations) and Endocrine and Autonomic Systems (100 citations). Keith Finlayson has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include John Sharkey, Louise Dickson, John Kelly, Jared W. Young, Hugh Marston, Christopher Spratt, Nicola Crawford, Lorraine E. Kerr, Donald J. Davidson and Deborah A. Sawatzky. Their work appears in journals such as European Journal of Pharmacology, Physical Review A, Neuropharmacology, Annales Geophysicae and Journal of Physics B Atomic Molecular and Optical Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact